$SIGA
SIGA Technologies Inc Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000143774923022546 Filed on August 08, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$9.235M	$5.878M
YoY Change	-87.21%	-64.73%
Cost Of Revenue	$896.5K	$974.4K
YoY Change	-77.3%	10.47%
Gross Profit	$8.339M	$4.904M
YoY Change	-87.78%	-68.93%
Gross Profit Margin	90.29%	83.42%
Selling, General & Admin	$6.000M	$4.426M
YoY Change	-69.48%	-24.65%
% of Gross Profit	71.95%	90.26%
Research & Development	$3.648M	$5.116M
YoY Change	-36.37%	-25.2%
% of Gross Profit	43.75%	104.33%
Depreciation & Amortization	$140.0K	$133.7K
YoY Change	7.53%	3.85%
% of Gross Profit	1.68%	2.73%
Operating Expenses	$9.648M	$9.542M
YoY Change	-62.0%	-24.95%
Operating Profit	-$1.309M	-$4.638M
YoY Change	-103.05%	-251.05%
Interest Expense	$0.00	$0.00
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	$883.1K	$1.191M
YoY Change	241.02%	1545.23%
Pretax Income	-$426.1K	-$3.448M
YoY Change	-100.99%	-207.99%
Income Tax	-$33.03K	-$600.0K
% Of Pretax Income
Net Earnings	-$393.1K	-$2.875M
YoY Change	-101.19%	-241.16%
Net Earnings / Revenue	-4.26%	-48.92%
Basic Earnings Per Share	-$0.01	-$0.04
Diluted Earnings Per Share	-$0.01	-$0.04
COMMON SHARES
Basic Shares Outstanding	71.08M	71.27M
Diluted Shares Outstanding	71.08M	71.09M

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$71.10M	$76.21M
YoY Change	-35.22%	-33.46%
Cash & Equivalents	$71.11M	$76.21M
Short-Term Investments
Other Short-Term Assets	$1.900M	$1.561M
YoY Change	97.08%	-49.38%
Inventory	$64.95M	$50.50M
Prepaid Expenses
Receivables	$8.050M	$6.027M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$146.0M	$134.3M
YoY Change	-25.87%	-12.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.469M	$1.605M
YoY Change	-25.77%	-23.91%
Goodwill	$898.3K	$898.3K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.145M	$2.117M
YoY Change	719.26%	749.77%
Total Long-Term Assets	$12.41M	$12.21M
YoY Change	69.46%	93.94%
TOTAL ASSETS
Total Short-Term Assets	$146.0M	$134.3M
Total Long-Term Assets	$12.41M	$12.21M
Total Assets	$158.4M	$146.5M
YoY Change	-22.45%	-8.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$564.3K	$1.081M
YoY Change	-76.93%	-10.97%
Accrued Expenses	$30.13M	$17.89M
YoY Change	89.62%	20.55%
Deferred Revenue	$21.90M	$11.37M
YoY Change	116.21%	61.68%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$30.74M	$18.99M
YoY Change	11.98%	13.74%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.500M	$3.449M
YoY Change	-3.58%	-0.83%
Total Long-Term Liabilities	$3.500M	$3.449M
YoY Change	-3.58%	-0.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$30.74M	$18.99M
Total Long-Term Liabilities	$3.500M	$3.449M
Total Liabilities	$34.24M	$22.44M
YoY Change	10.15%	11.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$111.2M	-$110.8M
YoY Change	84.9%	18.91%
Common Stock	$235.3M	$234.9M
YoY Change	0.88%	0.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$124.1M	$124.1M
YoY Change
Total Liabilities & Shareholders Equity	$158.4M	$146.5M
YoY Change	-22.45%	-8.4%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$393.1K	-$2.875M
YoY Change	-101.19%	-241.16%
Depreciation, Depletion And Amortization	$140.0K	$133.7K
YoY Change	7.53%	3.85%
Cash From Operating Activities	-$5.100M	-$3.580M
YoY Change	6.66%	62.16%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$21.69K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$21.69K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-35.87M
YoY Change		-1.8%
NET CHANGE
Cash From Operating Activities	-5.100M	-3.580M
Cash From Investing Activities	0.000	-21.69K
Cash From Financing Activities	0.000	-35.87M
Net Change In Cash	-5.100M	-39.47M
YoY Change	6.66%	1.91%
FREE CASH FLOW
Cash From Operating Activities	-$5.100M	-$3.580M
Capital Expenditures	$0.00	$21.69K
Free Cash Flow	-$5.100M	-$3.602M
YoY Change	6.66%	63.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71082944
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71082944
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	72675190
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72675190
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	300000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	300000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q2	us-gaap	Other Liabilities OtherLiabilities	3448558	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	3358160	usd
CY2023Q2	us-gaap	Liabilities Liabilities	22436703	usd
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-23047
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-3864870
	dei	Entity Address Address Line1 EntityAddressAddressLine1	31 East 62nd Street
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10065
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	City Area Code CityAreaCode	212
	dei	Local Phone Number LocalPhoneNumber	672-9100
	dei	Security12b Title Security12bTitle	common stock, $.0001 par value
	dei	Trading Symbol TradingSymbol	SIGA
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	71082944
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76213484	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	98790622	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6026887	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	45406960	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	50497103	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	39273090	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1560626	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2315672	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	134298100	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	185786344	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1605222	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1848314	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	7591743	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	6250385	usd
CY2023Q2	us-gaap	Goodwill Goodwill	898334	usd
CY2022Q4	us-gaap	Goodwill Goodwill	898334	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2117360	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	252546	usd
CY2023Q2	us-gaap	Assets Assets	146510759	usd
CY2022Q4	us-gaap	Assets Assets	195035923	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1081337	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3355268	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17894986	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16852781	usd
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	11822	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1309672	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	18988145	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21517721	usd
CY2022Q4	us-gaap	Liabilities Liabilities	24875881	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	7109	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7268	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	234873128	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	233957767	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-110806181	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63804993	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	124074056	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	170160042	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	146510759	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	195035923	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5878166	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16667045	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14201190	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	27206345	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	974420	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	882096	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2124608	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5602212	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4425959	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5874139	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8661068	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9585427	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5116154	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6840099	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10162189	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10386876	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	10516533	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	13596334	usd
	us-gaap	Costs And Expenses CostsAndExpenses	20947865	usd
	us-gaap	Costs And Expenses CostsAndExpenses	25574515	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4638367	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	3070711	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6746675	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1631830	usd
CY2023Q2	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	0	usd
CY2022Q2	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	49559	usd
	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	0	usd
	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	400663	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1190705	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	72373	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2081334	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	95694	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3447662	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3192643	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4665341	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2128187	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-572186	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1155581	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-871608	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	452175	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2875476	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	2037062	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3793733	usd
	us-gaap	Net Income Loss NetIncomeLoss	1676012	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71090642
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72678333
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71640784
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72873366
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71090642
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73332888
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71640784
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73699226
	us-gaap	Net Income Loss NetIncomeLoss	-3793733	usd
	us-gaap	Net Income Loss NetIncomeLoss	1676012	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	264778	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	256237	usd
	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	-0	usd
	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	400663	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1130170	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	764208	usd
	siga	Inventory Write Down Net Of Credits InventoryWriteDownNetOfCredits	518551	usd
	siga	Inventory Write Down Net Of Credits InventoryWriteDownNetOfCredits	157740	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1341358	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-617207	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-39380073	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-64052328	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11742564	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2921257	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1109768	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	592168	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1935092	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1582679	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1297850	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-18572423	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	793764	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3270658	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20866971	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	54498658	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	21686	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	-0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21686	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	214794	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	12533	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11072511	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	10149704	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	32135118	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	32944314	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-43422423	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-43106551	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-22577138	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	11392107	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	98790622	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	103138819	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76213484	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114530926	usd
	siga	Conversion Of Warrants To Common Stock ConversionOfWarrantsToCommonStock	0	usd
	siga	Conversion Of Warrants To Common Stock ConversionOfWarrantsToCommonStock	6120778	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	59000000.0	usd
CY2023Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	3800000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4039460	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6370581	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	37447497	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	27038845	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9010146	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5863664	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	50497103	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	39273090	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	124074056	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6916550	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6894863	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5311328	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5046549	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1605222	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1848314	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	300000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11374910	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10581146	usd
CY2023Q2	siga	Accrued Research And Development Vendor Costs Current AccruedResearchAndDevelopmentVendorCostsCurrent	1962683	usd
CY2022Q4	siga	Accrued Research And Development Vendor Costs Current AccruedResearchAndDevelopmentVendorCostsCurrent	1551920	usd
CY2023Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1479651	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2378035	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1331903	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1245353	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	729513	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	536997	usd
CY2023Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	470768	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	31160	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17894986	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16852781	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2875476	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	2037062	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3793733	usd
	us-gaap	Net Income Loss NetIncomeLoss	1676012	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	49559	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	400663	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-2875476	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	1987503	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-3793733	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	1275349	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71090642
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72678333
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71640784
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72873366
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	654555
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	825860
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71090642
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73332888
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71640784
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73699226
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	51930
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	53353
CY2023Q2	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	24600000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5878166	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16667045	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14201190	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	27206345	usd
CY2023Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-3400000	usd
CY2022Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	3200000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-600000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1200000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-4700000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	2100000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-900000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	500000	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.166	pure
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.362	pure
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.187	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.212	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	162093460	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2875476	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3515456	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	214794	usd
CY2023Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	32135118	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	721440	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	170160042	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3793733	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	11072511	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	214794	usd
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	32135118	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1130170	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	124074056	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	167736796	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	2037062	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3576922	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q2	siga	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	6120778	usd
CY2022Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	32944314	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	395454	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	139768854	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	174314407	usd
	us-gaap	Net Income Loss NetIncomeLoss	1676012	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	10149704	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	12533	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
	siga	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	6120778	usd
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	32944314	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	764208	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	139768854	usd
CY2021Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	600000
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1700000
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	300000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	200000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	300000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y3M
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0453	pure
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	279946	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	678627	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	406994	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	409971	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	165916	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1941454	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	153208	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1788246	usd

Files In Submission

Name	View Source	Status
0001437749-23-022546-index-headers.html	Edgar Link	pending
0001437749-23-022546-index.html	Edgar Link	pending
0001437749-23-022546.txt	Edgar Link	pending
0001437749-23-022546-xbrl.zip	Edgar Link	pending
ex_516402.htm	Edgar Link	pending
ex_516403.htm	Edgar Link	pending
ex_516404.htm	Edgar Link	pending
ex_516405.htm	Edgar Link	pending
ex_532471.htm	Edgar Link	pending
ex_549929.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20230630.xsd	Edgar Link	pending
siga20230630_10q.htm	Edgar Link	pending
siga-20230630_lab.xml	Edgar Link	unprocessable
siga-20230630_pre.xml	Edgar Link	unprocessable
siga20230630_10q_htm.xml	Edgar Link	completed
siga-20230630_def.xml	Edgar Link	unprocessable
siga-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA Technologies Inc Stock $siga

2023 Q3 Form 10-Q Financial Statement

#000143774923022546 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA Technologies Inc Stock $siga

2023 Q3 Form 10-Q Financial Statement

#000143774923022546 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA Technologies Inc Stock $siga